Article By:
Small Cap Gems
Tuesday, March 31, 2015 11:40 AM EDT
OxiGene, a small and virtually unknown biotech stock on the Nasdaq, boasts an impressive pipeline, yet the stock now trades at exactly cash level after a major sell-off. With multiple near-term catalysts in sight, I think shares could rebound hard.
In this article: OXGN
Is OxiGene The Cheapest Biotech On The Nasdaq?
$OXGN looks very promising, thanks.